Recombinant KLK1: the next step in stroke and preeclampsia treatment
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
New research has discovered a key survival mechanism in metastatic melanoma, revealing that cancer c...
Researchers have discovered that pancreatic tumours evade the immune system by disguising themselves...
Unlock Exclusive Industry Insights